ACADIA Pharmaceuticals
ACAD
#3279
Rank
A$7.04 B
Marketcap
A$41.17
Share price
-0.95%
Change (1 day)
8.06%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): A$0.17 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.09 Billion. In 2025 the company made an earning of A$0.19 Billion a decrease over its 2024 earnings that were of A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B-11.62%
2025 A$0.19 B-46.18%
2024 A$0.36 B-605.67%
2023 -A$72.19 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.24 Billion-40.38%
2020 -A$0.4 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.35 Billion-15.04%
2017 -A$0.41 Billion6.33%
2016 -A$0.39 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$53.67 Million81.93%
2012 -A$29.5 Million-8.73%
2011 -A$32.32 Million-251.39%
2010 A$21.34 M-133.2%
2009 -A$64.31 Million-30.82%
2008 -A$92.96 Million6.43%
2007 -A$87.35 Million25.89%
2006 -A$69.38 Million36.99%
2005 -A$50.65 Million37.22%
2004 -A$36.91 Million19.96%
2003 -A$30.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B 22,469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.97 B 9,101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.02 B 26,940.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 8,237.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.23 Billion-239.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$54.64 Million-133.56%๐Ÿ‡บ๐Ÿ‡ธ USA